Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 248

1.

Robot-assisted laparoscopic prostatectomy versus open radical retropubic prostatectomy: 24-month outcomes from a randomised controlled study.

Coughlin GD, Yaxley JW, Chambers SK, Occhipinti S, Samaratunga H, Zajdlewicz L, Teloken P, Dunglison N, Williams S, Lavin MF, Gardiner RA.

Lancet Oncol. 2018 Jul 12. pii: S1470-2045(18)30357-7. doi: 10.1016/S1470-2045(18)30357-7. [Epub ahead of print]

PMID:
30017351
2.

Health Literacy and the Health Status of Men with Prostate Cancer.

Goodwin BC, March S, Zajdlewicz L, Osborne RH, Dunn J, Chambers SK.

Psychooncology. 2018 Jun 29. doi: 10.1002/pon.4834. [Epub ahead of print]

PMID:
29959807
3.

Geographical Variations in the Clinical Management of Colorectal Cancer in Australia: A Systematic Review.

Crawford-Williams F, March S, Ireland MJ, Rowe A, Goodwin B, Hyde MK, Chambers SK, Aitken JF, Dunn J.

Front Oncol. 2018 May 16;8:116. doi: 10.3389/fonc.2018.00116. eCollection 2018.

4.

Cancer care in regional Australia from the health professional's perspective.

Crawford-Williams F, Goodwin B, March S, Ireland MJ, Hyde MK, Chambers SK, Aitken JF, Dunn J.

Support Care Cancer. 2018 Apr 25. doi: 10.1007/s00520-018-4218-x. [Epub ahead of print]

PMID:
29696425
5.

Can exercise delay transition to active therapy in men with low-grade prostate cancer? A multicentre randomised controlled trial.

Galvão DA, Hayne D, Frydenberg M, Chambers SK, Taaffe DR, Spry N, Scuffham PA, Ware RS, Hart NH, Newton RU.

BMJ Open. 2018 Apr 20;8(4):e022331. doi: 10.1136/bmjopen-2018-022331.

6.

Randomized Phase II Trial of Carboplatin-Paclitaxel Versus Carboplatin-Paclitaxel-Trastuzumab in Uterine Serous Carcinomas That Overexpress Human Epidermal Growth Factor Receptor 2/neu.

Fader AN, Roque DM, Siegel E, Buza N, Hui P, Abdelghany O, Chambers SK, Secord AA, Havrilesky L, O'Malley DM, Backes F, Nevadunsky N, Edraki B, Pikaart D, Lowery W, ElSahwi KS, Celano P, Bellone S, Azodi M, Litkouhi B, Ratner E, Silasi DA, Schwartz PE, Santin AD.

J Clin Oncol. 2018 Jul 10;36(20):2044-2051. doi: 10.1200/JCO.2017.76.5966. Epub 2018 Mar 27.

PMID:
29584549
7.

MSR1 repeats modulate gene expression and affect risk of breast and prostate cancer.

Rose AM, Krishan A, Chakarova CF, Moya L, Chambers SK, Hollands M, Illingworth JC, Williams SMG, McCabe HE, Shah AZ, Palmer CNA, Chakravarti A, Berg JN, Batra J, Bhattacharya SS.

Ann Oncol. 2018 May 1;29(5):1292-1303. doi: 10.1093/annonc/mdy082.

PMID:
29509840
8.

Experiences of Australian men diagnosed with advanced prostate cancer: a qualitative study.

Chambers SK, Hyde MK, Laurie K, Legg M, Frydenberg M, Davis ID, Lowe A, Dunn J.

BMJ Open. 2018 Feb 17;8(2):e019917. doi: 10.1136/bmjopen-2017-019917.

9.

Cardiorespiratory Fitness and Body Composition Responses to Different Intensities and Frequencies of Exercise Training in Colorectal Cancer Survivors.

Devin JL, Jenkins DG, Sax AT, Hughes GI, Aitken JF, Chambers SK, Dunn JC, Bolam KA, Skinner TL.

Clin Colorectal Cancer. 2018 Jun;17(2):e269-e279. doi: 10.1016/j.clcc.2018.01.004. Epub 2018 Jan 11.

PMID:
29397328
10.

Web-Delivered Cognitive Behavioral Therapy for Distressed Cancer Patients: Randomized Controlled Trial.

Chambers SK, Ritterband LM, Thorndike F, Nielsen L, Aitken JF, Clutton S, Scuffham PA, Youl P, Morris B, Baade PD, Dunn J.

J Med Internet Res. 2018 Jan 31;20(1):e42. doi: 10.2196/jmir.8850.

11.

Effective Exercise Interventions for Patients and Survivors of Cancer Should be Supervised, Targeted, and Prescribed With Referrals From Oncologists and General Physicians.

Newton RU, Taaffe DR, Chambers SK, Spry N, Galvão DA.

J Clin Oncol. 2018 Mar 20;36(9):927-928. doi: 10.1200/JCO.2017.76.7400. Epub 2018 Jan 26. No abstract available.

PMID:
29373097
12.

Effects and moderators of psychosocial interventions on quality of life, and emotional and social function in patients with cancer: An individual patient data meta-analysis of 22 RCTs.

Kalter J, Verdonck-de Leeuw IM, Sweegers MG, Aaronson NK, Jacobsen PB, Newton RU, Courneya KS, Aitken JF, Armes J, Arving C, Boersma LJ, Braamse AMJ, Brandberg Y, Chambers SK, Dekker J, Ell K, Ferguson RJ, Gielissen MFM, Glimelius B, Goedendorp MM, Graves KD, Heiney SP, Horne R, Hunter MS, Johansson B, Kimman ML, Knoop H, Meneses K, Northouse LL, Oldenburg HS, Prins JB, Savard J, van Beurden M, van den Berg SW, Brug J, Buffart LM.

Psychooncology. 2018 Apr;27(4):1150-1161. doi: 10.1002/pon.4648. Epub 2018 Mar 15. Review.

13.

Predictors of long-term distress in female partners of men diagnosed with prostate cancer.

Hyde MK, Legg M, Occhipinti S, Lepore SJ, Ugalde A, Zajdlewicz L, Laurie K, Dunn J, Chambers SK.

Psychooncology. 2018 Mar;27(3):946-954. doi: 10.1002/pon.4617. Epub 2018 Jan 26.

PMID:
29268006
14.

"Prostate cancer is far more hidden…": Perceptions of stigma, social isolation and help-seeking among men with prostate cancer.

Ettridge KA, Bowden JA, Chambers SK, Smith DP, Murphy M, Evans SM, Roder D, Miller CL.

Eur J Cancer Care (Engl). 2018 Mar;27(2):e12790. doi: 10.1111/ecc.12790. Epub 2017 Nov 7.

PMID:
29112317
15.

Socio-demographic factors drive regional differences in participation in the National Bowel Cancer Screening Program - An ecological analysis.

Sun J, March S, Ireland MJ, Crawford-Williams F, Goodwin B, Hyde MK, Chambers SK, Aitken JF, Dunn J.

Aust N Z J Public Health. 2018 Feb;42(1):92-97. doi: 10.1111/1753-6405.12722. Epub 2017 Oct 18.

PMID:
29044846
16.

Exercise Preserves Physical Function in Prostate Cancer Patients with Bone Metastases.

Galvão DA, Taaffe DR, Spry N, Cormie P, Joseph D, Chambers SK, Chee R, Peddle-McIntyre CJ, Hart NH, Baumann FT, Denham J, Baker M, Newton RU.

Med Sci Sports Exerc. 2018 Mar;50(3):393-399. doi: 10.1249/MSS.0000000000001454.

17.

Time on androgen deprivation therapy and adaptations to exercise: secondary analysis from a 12-month randomized controlled trial in men with prostate cancer.

Taaffe DR, Buffart LM, Newton RU, Spry N, Denham J, Joseph D, Lamb D, Chambers SK, Galvão DA.

BJU Int. 2018 Feb;121(2):194-202. doi: 10.1111/bju.14008. Epub 2017 Sep 22.

PMID:
28872752
18.

Long-term Psychological and Quality-of-life Effects of Active Surveillance and Watchful Waiting After Diagnosis of Low-risk Localised Prostate Cancer.

Egger SJ, Calopedos RJ, O'Connell DL, Chambers SK, Woo HH, Smith DP.

Eur Urol. 2018 Jun;73(6):859-867. doi: 10.1016/j.eururo.2017.08.013. Epub 2017 Aug 26.

PMID:
28851582
19.

New Challenges in Psycho-Oncology Research III: A systematic review of psychological interventions for prostate cancer survivors and their partners: clinical and research implications.

Chambers SK, Hyde MK, Smith DP, Hughes S, Yuill S, Egger S, O'Connell DL, Stein K, Frydenberg M, Wittert G, Dunn J.

Psychooncology. 2017 Jul;26(7):873-913. doi: 10.1002/pon.4431. No abstract available.

20.

Randomized controlled trial of a peer led multimodal intervention for men with prostate cancer to increase exercise participation.

Galvão DA, Newton RU, Girgis A, Lepore SJ, Stiller A, Mihalopoulos C, Gardiner RA, Taaffe DR, Occhipinti S, Chambers SK.

Psychooncology. 2018 Jan;27(1):199-207. doi: 10.1002/pon.4495. Epub 2017 Jul 27.

PMID:
28685892
21.

A study protocol for a randomised controlled trial of an interactive web-based intervention: CancerCope.

Chambers SK, Ritterband L, Thorndike F, Nielsen L, Aitken JF, Clutton S, Scuffham P, Youl P, Morris B, Baade P, Dunn J.

BMJ Open. 2017 Jun 23;7(6):e017279. doi: 10.1136/bmjopen-2017-017279.

22.

Validation of the factor structure of the Five Facets of Mindfulness Questionnaire in men diagnosed with advanced prostate cancer.

Laurie K, Hyde MK, Lepore SJ, Chambers SK.

Psychooncology. 2018 Mar;27(3):1061-1064. doi: 10.1002/pon.4474. Epub 2017 Jun 29. No abstract available.

PMID:
28612404
23.

Can exercise suppress tumour growth in advanced prostate cancer patients with sclerotic bone metastases? A randomised, controlled study protocol examining feasibility, safety and efficacy.

Hart NH, Newton RU, Spry NA, Taaffe DR, Chambers SK, Feeney KT, Joseph DJ, Redfern AD, Ferguson T, Galvão DA.

BMJ Open. 2017 May 30;7(5):e014458. doi: 10.1136/bmjopen-2016-014458.

24.

What does it cost Medicare to diagnose and treat men with localized prostate cancer in the first year?

Mervin MC, Lowe A, Gardiner RA, Smith DP, Aitken J, Chambers SK, Gordon LG.

Asia Pac J Clin Oncol. 2017 Jun;13(3):152-159. doi: 10.1111/ajco.12663. Epub 2017 Mar 16.

PMID:
28303657
25.

Health-Related Quality of Life After the Diagnosis of Locally Advanced or Advanced Prostate Cancer: A Longitudinal Study.

Zajdlewicz L, Hyde MK, Lepore SJ, Gardiner RA, Chambers SK.

Cancer Nurs. 2017 Sep/Oct;40(5):412-419. doi: 10.1097/NCC.0000000000000432.

PMID:
28282307
26.

Effects of Different Exercise Modalities on Fatigue in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy: A Year-long Randomised Controlled Trial.

Taaffe DR, Newton RU, Spry N, Joseph D, Chambers SK, Gardiner RA, Wall BA, Cormie P, Bolam KA, Galvão DA.

Eur Urol. 2017 Aug;72(2):293-299. doi: 10.1016/j.eururo.2017.02.019. Epub 2017 Feb 27.

27.

Assessing robot-assisted laparoscopic prostatectomy - Authors' reply.

Yaxley JW, Coughlin GD, Chambers SK, Dunglison N, Gardiner RA.

Lancet. 2017 Feb 25;389(10071):800-801. doi: 10.1016/S0140-6736(17)30508-1. No abstract available.

PMID:
28248170
28.

Needy or resilient? How women with breast cancer think about peer support.

Legg M, Occhipinti S, Youl P, Dunn J, Chambers SK.

Psychooncology. 2017 Dec;26(12):2307-2310. doi: 10.1002/pon.4401. Epub 2017 Mar 20. No abstract available.

PMID:
28218987
29.

Erectile dysfunction, masculinity, and psychosocial outcomes: a review of the experiences of men after prostate cancer treatment.

Chambers SK, Chung E, Wittert G, Hyde MK.

Transl Androl Urol. 2017 Feb;6(1):60-68. doi: 10.21037/tau.2016.08.12. Review.

30.

A systematic review of geographical differences in management and outcomes for colorectal cancer in Australia.

Ireland MJ, March S, Crawford-Williams F, Cassimatis M, Aitken JF, Hyde MK, Chambers SK, Sun J, Dunn J.

BMC Cancer. 2017 Feb 2;17(1):95. doi: 10.1186/s12885-017-3067-1. Review.

31.

Advocacy, support and survivorship in prostate cancer.

Dunn J, Casey C, Sandoe D, Hyde MK, Cheron-Sauer MC, Lowe A, Oliffe JL, Chambers SK.

Eur J Cancer Care (Engl). 2018 Mar;27(2):e12644. doi: 10.1111/ecc.12644. Epub 2017 Feb 1.

32.

Expression of the cytoplasmic nucleolin for post-transcriptional regulation of macrophage colony-stimulating factor mRNA in ovarian and breast cancer cells.

Woo HH, Lee SC, Gibson SJ, Chambers SK.

Biochim Biophys Acta. 2017 Mar;1860(3):337-348. doi: 10.1016/j.bbagrm.2017.01.006. Epub 2017 Jan 25.

PMID:
28131007
33.

Trajectories of quality of life, life satisfaction, and psychological adjustment after prostate cancer.

Chambers SK, Ng SK, Baade P, Aitken JF, Hyde MK, Wittert G, Frydenberg M, Dunn J.

Psychooncology. 2017 Oct;26(10):1576-1585. doi: 10.1002/pon.4342. Epub 2017 Jan 11.

34.

Clinical Translation of Tumor Acidosis Measurements with AcidoCEST MRI.

Jones KM, Randtke EA, Yoshimaru ES, Howison CM, Chalasani P, Klein RR, Chambers SK, Kuo PH, Pagel MD.

Mol Imaging Biol. 2017 Aug;19(4):617-625. doi: 10.1007/s11307-016-1029-7.

35.

Mindfulness-Based Cognitive Therapy in Advanced Prostate Cancer: A Randomized Controlled Trial.

Chambers SK, Occhipinti S, Foley E, Clutton S, Legg M, Berry M, Stockler MR, Frydenberg M, Gardiner RA, Lepore SJ, Davis ID, Smith DP.

J Clin Oncol. 2017 Jan 20;35(3):291-297. doi: 10.1200/JCO.2016.68.8788. Epub 2016 Nov 21.

PMID:
27870567
36.

The Impact of Rurality and Disadvantage on the Diagnostic Interval for Breast Cancer in a Large Population-Based Study of 3202 Women in Queensland, Australia.

Youl PH, Aitken JF, Turrell G, Chambers SK, Dunn J, Pyke C, Baade PD.

Int J Environ Res Public Health. 2016 Nov 19;13(11). pii: E1156.

37.

Barriers to lung cancer care: health professionals' perspectives.

Dunn J, Garvey G, Valery PC, Ball D, Fong KM, Vinod S, O'Connell DL, Chambers SK.

Support Care Cancer. 2017 Feb;25(2):497-504. doi: 10.1007/s00520-016-3428-3. Epub 2016 Oct 10.

38.

An investigation of the emotion of disgust as an affective barrier to intention to screen for colorectal cancer.

Davis M, Oaten M, Occhipinti S, Chambers SK, Stevenson RJ.

Eur J Cancer Care (Engl). 2017 Jul;26(4). doi: 10.1111/ecc.12582. Epub 2016 Oct 5.

PMID:
27704647
39.

Associations between aerobic exercise levels and physical and mental health outcomes in men with bone metastatic prostate cancer: a cross-sectional investigation.

Zopf EM, Newton RU, Taaffe DR, Spry N, Cormie P, Joseph D, Chambers SK, Baumann FT, Bloch W, Galvão DA.

Eur J Cancer Care (Engl). 2017 Nov;26(6). doi: 10.1111/ecc.12575. Epub 2016 Sep 20.

PMID:
27647712
40.

Robot-assisted laparoscopic prostatectomy versus open radical retropubic prostatectomy: early outcomes from a randomised controlled phase 3 study.

Yaxley JW, Coughlin GD, Chambers SK, Occhipinti S, Samaratunga H, Zajdlewicz L, Dunglison N, Carter R, Williams S, Payton DJ, Perry-Keene J, Lavin MF, Gardiner RA.

Lancet. 2016 Sep 10;388(10049):1057-1066. doi: 10.1016/S0140-6736(16)30592-X. Epub 2016 Jul 26.

PMID:
27474375
41.

Can atorvastatin with metformin change the natural history of prostate cancer as characterized by molecular, metabolomic, imaging and pathological variables? A randomized controlled trial protocol.

Roberts MJ, Yaxley JW, Coughlin GD, Gianduzzo TR, Esler RC, Dunglison NT, Chambers SK, Medcraft RJ, Chow CW, Schirra HJ, Richards RS, Kienzle N, Lu M, Brereton I, Samaratunga H, Perry-Keene J, Payton D, Oyama C, Doi SA, Lavin MF, Gardiner RA.

Contemp Clin Trials. 2016 Sep;50:16-20. doi: 10.1016/j.cct.2016.06.014. Epub 2016 Jun 28.

PMID:
27370230
42.

The role of mindfulness in distress and quality of life for men with advanced prostate cancer.

Chambers SK, Foley E, Clutton S, McDowall R, Occhipinti S, Berry M, Stockler MR, Lepore SJ, Frydenberg M, Gardiner RA, Davis ID, Smith DP.

Qual Life Res. 2016 Dec;25(12):3027-3035. Epub 2016 Jun 17.

43.

Noninvasive detection of enzyme activity in tumor models of human ovarian cancer using catalyCEST MRI.

Sinharay S, Randtke EA, Jones KM, Howison CM, Chambers SK, Kobayashi H, Pagel MD.

Magn Reson Med. 2017 May;77(5):2005-2014. doi: 10.1002/mrm.26278. Epub 2016 May 25.

44.

Multispectral fluorescence imaging of human ovarian and fallopian tube tissue for early-stage cancer detection.

Tate TH, Baggett B, Rice PF, Koevary JW, Orsinger GV, Nymeyer AC, Welge WA, Saboda K, Roe DJ, Hatch KD, Chambers SK, Utzinger U, Barton JK.

J Biomed Opt. 2016 May 1;21(5):56005. doi: 10.1117/1.JBO.21.5.056005. No abstract available.

45.

Men's help-seeking in the first year after diagnosis of localised prostate cancer.

Hyde MK, Newton RU, Galvão DA, Gardiner RA, Occhipinti S, Lowe A, Wittert GA, Chambers SK.

Eur J Cancer Care (Engl). 2017 Mar;26(2). doi: 10.1111/ecc.12497. Epub 2016 Apr 25.

46.

Assessment of the Role of Intraoperative Frozen Section in Guiding Surgical Staging for Endometrial Cancer.

Wang X, Li L, Cragun JM, Chambers SK, Hatch KD, Zheng W.

Int J Gynecol Cancer. 2016 Jun;26(5):918-23. doi: 10.1097/IGC.0000000000000692.

PMID:
27051054
47.

Enhancing active surveillance of prostate cancer: the potential of exercise medicine.

Galvão DA, Taaffe DR, Spry N, Gardiner RA, Taylor R, Risbridger GP, Frydenberg M, Hill M, Chambers SK, Stricker P, Shannon T, Hayne D, Zopf E, Newton RU.

Nat Rev Urol. 2016 May;13(5):258-65. doi: 10.1038/nrurol.2016.46. Epub 2016 Mar 8. Review.

PMID:
26954333
48.

Impact of a brief exercise program on the physical and psychosocial health of prostate cancer survivors: A pilot study.

Skinner TL, Peeters GG, Croci I, Bell KR, Burton NW, Chambers SK, Bolam KA.

Asia Pac J Clin Oncol. 2016 Sep;12(3):225-34. doi: 10.1111/ajco.12474. Epub 2016 Feb 28.

PMID:
26923217
49.

Mechanism of progestin resistance in endometrial precancer/cancer through Nrf2-AKR1C1 pathway.

Wang Y, Wang Y, Zhang Z, Park JY, Guo D, Liao H, Yi X, Zheng Y, Zhang D, Chambers SK, Zheng W.

Oncotarget. 2016 Mar 1;7(9):10363-72. doi: 10.18632/oncotarget.7004.

50.

Medical Help-Seeking for Sexual Concerns in Prostate Cancer Survivors.

Hyde MK, Zajdlewicz L, Wootten AC, Nelson CJ, Lowe A, Dunn J, Chambers SK.

Sex Med. 2016 Mar;4(1):e7-e17. doi: 10.1016/j.esxm.2015.12.004. Epub 2016 Jan 11.

Supplemental Content

Loading ...
Support Center